Regulation (EU) No 1259/2013

In force

This text since 30 Dec 2013law://eu/reg/2013/1259/art_1__pnt_17@2026-11-14

Contents

(17)Article 28 is replaced by the following:‘Article 28In addition to the measures referred to in Article 26, the Commission shall be empowered to lay down, where necessary, by means of implementing acts, measures to ensure the effective monitoring of trade between the Union and third countries in drug precursors, in particular with regard to the design and use of export and import authorisation forms, for the purpose of preventing the diversion of drug precursors. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 30(2).’;

Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.

Key facts

Type: Regulation · (EU) No 1259/2013
Adopted: 20 Nov 2013
In force: 30 Dec 2013
Made by: Council of the European Union, European Parliament
Official: EUR-Lex 32013R1259 · ELI

Topics

database drug traffic EU control export monitoring market supervision medicinal product psychotropic substance surveillance concerning imports trade intermediary Justice and home affairs Public health

History · 1 version

30 Dec 2013Reading

Connections

See on a map

Amends 1: Council Regulation (EC) No 111/2005
Cited by 5: Criminal proceedings against TF (C-806/21); Commission Delegated Regulation (EU) 2015/10112 provisions; Commission Implementing Regulation (EU) 2015/10134 provisions; N.F. Gielen and Others (C-369/13); Miguel M. and Others (C-627/13, C-2/14)4 provisions

Defined terms · 3

Show every defined term

import
means any entry of scheduled substances having the status of non-Union goods into the customs territory of the Union, including temporary storage, the placing in a free zone or free warehouse, the placing under a suspensive procedure and the release for free circulation within the meaning of Council Regulation (EEC) No 2913/92;
natural product
means an organism or a part thereof, in any form, or any substances which occur in nature as defined in point 39 of Article 3 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council;
scheduled substance
means any substance listed in the Annex that can be used for the illicit manufacture of narcotic drugs or psychotropic substances, including mixtures and natural products containing such substances, but excluding mixtures and natural products which contain scheduled substances and which are compounded in such a way that the scheduled substances cannot be easily used or extracted by readily applicable or economically viable means, medicinal products as defined in point 2 of Article 1 of Directive 2001/83/EC of the European Parliament and of the Council and veterinary medicinal products as defined in point 2 of Article 1 of Directive 2001/82/EC of the European Parliament and of the Council, except medicinal products and veterinary medicinal products listed in the Annex;